Robert F Mullins Selected Research

North Carolina type 1 retinal Macular dystrophy

1/2016

North Carolina Macular Dystrophy Is Caused by Dysregulation of the Retinal Transcription Factor PRDM13.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert F Mullins Research Topics

Disease

32	Macular Degeneration (Age-Related Maculopathy) 10/2023 - 07/2005
12	Retinal Degeneration 01/2022 - 06/2004
11	Retinitis Pigmentosa (Pigmentary Retinopathy) 12/2023 - 09/2005
10	Blindness (Hysterical Blindness) 12/2023 - 01/2016
9	Retinal Diseases 04/2024 - 02/2011
6	Inflammation (Inflammations) 01/2023 - 06/2010
6	Ganglion Cysts (Ganglion) 12/2021 - 01/2007
5	Vitelliform Macular Dystrophy 12/2014 - 11/2005
4	Glaucoma 12/2021 - 01/2012
4	Infections 01/2020 - 05/2011
4	Burns 11/2017 - 11/2007
3	Wounds and Injuries (Trauma) 01/2023 - 12/2008
3	Stargardt Disease 03/2022 - 12/2013
3	Open-Angle Glaucoma (Glaucoma, Open Angle) 11/2019 - 01/2012
3	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2019 - 01/2016
2	Retinal Dystrophies 12/2023 - 03/2022
2	Geographic Atrophy 12/2022 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 01/2017
2	Retinal Perforations 05/2020 - 05/2015
2	Epiretinal Membrane (Epiretinal Membranes) 05/2020 - 02/2019
2	Retinal Detachment (Retinal Detachments) 05/2020 - 02/2019
2	Vascular Diseases (Vascular Disease) 01/2020 - 11/2019
2	Neoplasms (Cancer) 01/2016 - 02/2011
2	Eye Diseases (Eye Disease) 02/2012 - 12/2010
2	Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl) 07/2007 - 06/2004
1	Disease Progression 01/2023
1	Stroke (Strokes) 01/2023
1	Lactic Acidosis 01/2023
1	Mitochondrial encephalopathy 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	MELAS Syndrome (Syndrome, MELAS) 01/2023
1	Deafness (Deaf Mutism) 03/2022
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 03/2022
1	Iron Overload 01/2022
1	Common Variable Immunodeficiency 01/2022
1	Telangiectasis (Telangiectasia) 12/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Usher Syndromes (Usher Syndrome) 10/2020
1	Vitreous Hemorrhage 05/2020
1	Necrosis 01/2020
1	Macular Edema 12/2019
1	Fibrosis (Cirrhosis) 02/2019
1	Retinoschisis (Retinoschisis, Juvenile) 01/2019
1	Genomic Instability 01/2019
1	Enhanced S-Cone Syndrome 01/2019
1	Optic Nerve Diseases (Optic Neuropathy) 12/2018
1	Oxyphilic Adenoma (Oncocytoma) 12/2018
1	renal Oncocytoma 12/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018

Drug/Important Bio-Agent (IBA)

40	Retinaldehyde (Retinal)IBA 04/2024 - 11/2006
12	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2004
7	Complement System Proteins (Complement)IBA 01/2022 - 10/2010
6	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2007
4	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2013
4	AntibodiesIBA 01/2014 - 12/2010
3	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2012
3	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 11/2018 - 11/2014
3	Phosphotransferases (Kinase)IBA 01/2017 - 08/2011
3	BestrophinsIBA 07/2007 - 11/2005
2	Rhodopsin (Visual Purple)IBA 12/2023 - 09/2005
2	C-Reactive ProteinIBA 11/2018 - 10/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2015 - 03/2008
2	Glycoproteins (Glycoprotein)IBA 05/2011 - 04/2002
2	GlycoconjugatesIBA 07/2007 - 07/2005
1	ChromatinIBA 01/2023
1	Mitochondrial DNA (mtDNA)IBA 01/2023
1	BuffersIBA 01/2023
1	Type 6 Cyclic Nucleotide PhosphodiesterasesIBA 01/2023
1	enhanced green fluorescent proteinIBA 01/2023
1	chemotactic factor inactivatorIBA 12/2022
1	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 03/2022
1	SodiumIBA 03/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	polycaprolactoneIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	IronIBA 01/2022
1	Complement Factor H (Factor H)IBA 01/2022
1	Retinal Pigments (Pigments, Visual)IBA 01/2022
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2021
1	Angiotensin IIIBA 01/2021
1	Toll-Like Receptor 2IBA 01/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 12/2019
1	Amyloid (Amyloid Fibrils)IBA 11/2019
1	Bevacizumab (Avastin)FDA Link 02/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2019
1	B-Form DNA (B-DNA)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	AgglutininsIBA 01/2019
1	Phosphopyruvate Hydratase (Enolase)IBA 12/2018
1	Endoplasmic Reticulum Chaperone BiPIBA 09/2018
1	trabecular meshwork-induced glucocorticoid response proteinIBA 09/2018

Therapy/Procedure

10	Therapeutics 01/2023 - 03/2010
5	Transplantation 01/2018 - 01/2013
2	Lasers (Laser) 10/2023 - 06/2023
2	Vitrectomy 05/2020 - 05/2015
2	Length of Stay 07/2009 - 11/2007
1	Negative-Pressure Wound Therapy 01/2023
1	Surgical Amputation (Amputations) 01/2020
1	Traction 02/2019